PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Urovant licenses overactive bladder drug to Pierre Fabre

Urovant Sciences and Pierre Fabre Médicament have entered into an exclusive license agreement allowing the French pharma/cosmetics company to register and ...
Continue Reading →
News

FDA advisory committee to review Amylyx ALS drug again

The FDA will reconvene its Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) to discuss Amylyx’s ALS drug candidate later this year, the compa...
Continue Reading →
News

AlzeCure’s Alzheimer’s candidate shows promise

The treatment abstract focuses on results from a multiple ascending dose study in healthy volunteers. AlzeCure Pharma – a company that develops a portfolio of sma...
Continue Reading →
News

Bloom’s smart CRP test gets green light

C-Reactive protein test gets the go-ahead for professional use across Europe. Swiss Medtech company Bloom Diagnostics has announced the launch of the Bloom Inflam...
Continue Reading →
News

Advanz finalises acquisition of Intercept operations across Europe and Canada

The deal will give Advanz an increased presence in the treatment of rare diseases. Advanz Pharma has announced that it has successfully completed the acquisition ...
Continue Reading →
News

Innovative Trials acquires first US office

The development is part of the company’s mission to support patient access to clinical trials. Innovative Trials – the UK-based global clinical trial patient recr...
Continue Reading →
News

Sanofi’s Xenpozyme approved by European Commission

Xenpozyme is a treatment for ASMD and the condition’s only current enzyme replacement therapy The European Commission has approved Xenpozyme – also known as olipu...
Continue Reading →
News

Recommendation for Novartis’ chronic myeloid leukaemia STAMP inhibitor

Chronic myeloid leukaemia therapy Scemblix receives NICE final draft recommendation in Britain. Novartis has announced that eligible patients in England and Wales...
Continue Reading →
News

Novo Nordisk to build on heritage in rare blood disorders

New data will be released at the International Society on Thrombosis and Haemostasis Congress. Novo Nordisk is advancing its ambition to drive change in rare dise...
Continue Reading →
News

AbbVie’s Rinvoq gains recommended approval by CHMP

CHMP returns a positive opinion on Rinvoq for the treatment of adults with active non-radiographic axial spondyloarthritis. AbbVie has announced that the European...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026